Archives

Trepwise: How This Consulting Firm Unlocks The Potential of Purpose-Driven Organizations

By Amit Chowdhry ● Jan 5, 2024

Trepwise is a strategy consulting firm focused on unlocking the potential of purpose-driven organizations by aligning people, processes, and vision. Pulse 2.0 interviewed Trepwise founder and CEO Kevin Wilkins to learn more about the company.

One Point One Solutions: The Story Behind This Business Process Management Company

By Amit Chowdhry ● Jan 5, 2024

One Point One Solutions is a leading next-generation Business Process Management (BPM) company that offers solutions to some of India's most loved brands. Pulse 2.0 interviewed One Point One Solutions managing director Akshay Chhabra to learn more about the company.

Graviton Bioscience Receives Financing From Enavate Sciences

By Noah Long ● Jan 4, 2024

Graviton Bioscience - a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) - recently announced the completion of financing from Enavate Sciences, a portfolio company of Patient Square Capital.

Intel And DigitalBridge Form Articul8 To Offer Enterprise GenAI Software Platform

By Amit Chowdhry ● Jan 4, 2024

Intel and global investment firm DigitalBridge Group announced the formation of Articul8 AI, an independent company offering enterprise customers a full-stack, vertically-optimized, and secure generative artificial intelligence (GenAI) software platform. And the platform delivers AI capabilities that keep customer data, training, and inference within the enterprise security perimeter.

Forward Consumer Partners: Debut Fund Closed At $425 Million Hard Cap

By Amit Chowdhry ● Jan 4, 2024

Forward Consumer Partners - a private equity firm that invests in branded consumer businesses - announced recently the successful closing of its oversubscribed debut fund, Forward Fund I (Fund I).

iGrafx: Transforming Process Intelligence To Drive Business Outcomes

By Amit Chowdhry ● Jan 4, 2024

iGrafx is a global leader in process intelligence, enabling the world’s enterprises to turn processes into a competitive advantage. Pulse 2.0 interviewed iGrafx chief executive officer Alexandre Wentzo to learn more about the company.

Vasa Therapeutics Raises $6 Million In Seed Funding To Develop Therapies For Cardiovascular Aging Diseases

By Dan Anderson ● Jan 4, 2024

Vasa Therapeutics - a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging - recently announced the closing of $6 million in series seed funding led by Orphinic Scientific SA. The funding round also included participation from private investment funds NuFund Venture Group, SeedFolio, and others.

Radionetics Oncology: $52.5 Million Secured To Advance Radiopharmaceutical Pipeline

By Annie Baker ● Jan 4, 2024

Radionetics Oncology - a clinical-stage radiopharmaceutical company focused on discovering and developing novel agents for treating a wide range of oncology indications - recently announced the completion of a $52.5 million Series A financing. The funding round was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC Bio, with participation from Crinetics Pharmaceuticals and GordonMD Global Investments, raising the total to $82.5 million.

Aqua Security: $60 Million Funding Raised At Over $1 Billion Valuation

By Amit Chowdhry ● Jan 4, 2024

Aqua Security - a pioneer in cloud-native security - recently announced it had secured $60 million in funding, led by new investor Evolution Equity Partners, with participation from existing investors Insight Partners, Lightspeed Venture Partners, and StepStone Group. The funding - which is an extension of the company’s Series E round - placed Aqua’s valuation above $1 billion.

Vita Inclinata: $44 Million Closed To Create A Safety Ecosystem For Rescue Crews

By Noah Long ● Jan 4, 2024

Vita Inclinata Technologies - an innovator in intelligent lifting hardware and software for rescue crews and other field safety applications - recently announced that it secured $44 million in funding from 3&1 Fund, a global leader in IP (Intellectual Property) based financing solutions. Utilizing a debt structure, 3&1 Fund offered a compelling alternative to traditional equity-based venture capital financing, which will boost Vita Inclinata Technologies' expansion initiatives.

Remix Therapeutics: $60 Million Raised To Develop Small Molecule Therapies To Modulate RNA Processing

By Amit Chowdhry ● Jan 4, 2024

Remix Therapeutics - a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease - recently announced closing a $60 million financing led by The Column Group.

BioCentriq: Cell-Based Therapy CDMO Company Secures $29.2 Million

By Annie Baker ● Jan 4, 2024

BioCentriq - a global cell-based therapy Contract Development and Manufacturing Organization (CDMO) - recently announced the successful completion of its latest round of fundraising, securing $29.2 million in capital investment. The funding round presents a significant milestone in BioCentriq's mission to accelerate the delivery of innovative cell therapies by translating, optimizing, and scaling processes for GMP manufacture.

Why SentinelOne Is Buying PingSafe

By Amit Chowdhry ● Jan 3, 2024

SentinelOne - a global leader in AI-powered security - announced today that it has agreed to acquire PingSafe. The acquisition of PingSafe’s cloud-native application protection platform (CNAPP) - when combined with SentinelOne’s cloud workload security and cloud data security capabilities - will provide companies with a fully integrated platform that drives better coverage, hygiene, and automation across their entire cloud footprint.

Apollo Therapeutics: Second Close Of Series C Funding Brings Total Raised To $260 Million

By Annie Baker ● Jan 3, 2024

Apollo Therapeutics - a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach - recently announced that during December 2023, it completed a second close of its Series C financing, raising an additional $33.5 million and bringing the total raised in this round by the company during 2023 to $260 million.

NewSpring: Fourth Growth Equity Healthcare Fund Exceeds Target At Over $180 Million

By Amit Chowdhry ● Jan 3, 2024

NewSpring - a family of private equity strategies investing in the lower-middle market - recently announced the final close of its oversubscribed fourth healthcare fund NewSpring Health Capital IV (NSH IV), raising over $180 million.

Franklin Templeton Completes Putnam Investments Acquisition

By Dan Anderson ● Jan 3, 2024

Franklin Resources - a global investment management organization operating as Franklin Templeton - recently announced the successful completion on January 1, 2024, of its acquisition of Putnam Investments from Great-West Lifeco. Per the terms of the deal, Great-West becomes a long-term shareholder in Franklin Resources, consistent with Great-West’s continuing commitment to asset management.

Robin AI: Legal Copilot Company Secures $26 Million

By Noah Long ● Jan 3, 2024

EIG To Buy Ocyan For $390 Million: Details

By Annie Baker ● Jan 3, 2024

EIG - a leading institutional investor in the global energy and infrastructure sectors - recently announced that it has entered into definitive agreements with Novonor S.A. and Brazilian Development Bank (BNDES) to acquire Ocyan Participações S.A., a Brazilian-based solutions provider to the offshore oil and gas industry, for a total amount of $390 million, considering $283 million for Novonor’s 100% equity interest and the remaining amount for liquidation of its outstanding balance of non-voting securities related to the company.

Luna: $50 Million In Funding And Silixa Acquisition

By Amit Chowdhry ● Jan 3, 2024

Luna Innovations - a global leader in advanced fiber optic-based technology - recently announced a $50 million investment by White Hat Capital Partners, an investment firm focused on sustainable value creation in technology companies serving mission-critical applications. The proceeds from this strategic investment were partially used to fund the acquisition of Silixa and related transaction costs in the aggregate amount of approximately $25 million.

Shield AI: Aircraft AI Pilot Company Expands Series F Funding Round To $500 Million

By Amit Chowdhry ● Jan 3, 2024

Shield AI - a defense technology company building the best AI pilot for aircraft - recently announced the expansion of their Series F funding round to $500 million. An additional $100 million in equity, raised at the Series F price, and $200 million in debt from Hercules Capital were added to the initial $200 million in equity closed in November.

Heranova Lifesciences: $13.5 Million Raised To Develop Women’s Health Solutions

By Annie Baker ● Jan 3, 2024

Heranova Lifesciences Holding Ltd. recently announced the successful completion of a $13.5 million seed and seed+ financing to develop and offer integrated Women's Health solutions worldwide. This funding round will be used to launch a series of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis.

VinFast: How This Company Plans To Make EVs Smarter And More Accessible

By Amit Chowdhry ● Jan 3, 2024

VinFast is a company that has emerged not just as an automaker but as a visionary in the realm of intelligent mobility. And the company's mission is clear: to make electric vehicles smarter and more accessible, propelling people worldwide toward a sustainable future. Pulse 2.0 interviewed Nguyen Thi Van Anh, CEO of VinFast US Manufacturing, to learn more about the company.

Sonera: Building High-Performance Sensors To Make Neural Data Accessible On A Wide Scale

By Amit Chowdhry ● Jan 3, 2024

Sonera is an early-stage startup developing high-performance sensors for non-invasive brain-computer interfaces with the goal of making neural data accessible on a wide scale. Pulse 2.0 interviewed Sonera CEO and co-founder Nishita Deka to learn more about the company.

Strada: Improving Workflow Efficiency And Automation For Creatives

By Amit Chowdhry ● Jan 3, 2024

Strada is a company that is improving workflow efficiency and automation by developing the first A.I. marketplace for creatives. The company was founded by CEO Michael Cioni. Cioni is a four-time Emmy Award winner, and he was the co-founder and CEO of the post-house Light Iron (acquired by Panavision) and served as product director for Panavision's Millennium DXL 8K camera ecosystem. As Senior Director of Global Innovation at Frame.io (an Adobe company), Cioni also led numerous workflow innovations, including the transformative Camera to Cloud technology. Pulse 2.0 interviewed Cioni to learn more about the company.

Myers Industries Buying Signature Systems For About $350 Million

By Annie Baker ● Jan 2, 2024

Myers Industries - a leading manufacturer and distributor of industrial products - announced today that it has entered into an agreement and plan of merger. Myers will acquire Signature Systems, a leader in composite ground protection solutions. These are the details.

EchoStar And DISH Network Complete Merger

By Noah Long ● Jan 2, 2024

Today, EchoStar announced the completion of its acquisition of DISH Network on December 31, 2023. To complete the acquisition, a wholly owned subsidiary of EchoStar has merged with and into DISH Network, with DISH Network surviving the merger as a wholly owned subsidiary of EchoStar.

ImmunityBio: Up To $320 Million Investment Being Provided By Oberland Capital

By Amit Chowdhry ● Jan 2, 2024

ImmunityBio - a clinical-stage immunotherapy company- announced today an up to $320 million royalty financing and equity investment in the company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023. The additional investment provides significant financial resources for the company to accelerate its commercialization efforts in anticipation of a potential regulatory approval and expand its pipeline within the broader urological cancer space. The proceeds will also fund ongoing business operations and clinical trials expanding N-803 (Anktiva) indications into multiple solid tumors.

UltiHash: Sustainable Data Storage Solution Company Raises $2.5 Million

By Amit Chowdhry ● Jan 2, 2024

UltiHash - the first high-performance and sustainable data storage solution - recently announced it has raised $2.5 million in pre-seed funding. This funding round was led by Inventure, with participation from PreSeedVentures, Tiny VC, Futuristic VC, The Nordic Web, Antti Karjalainen (founder of Robocorp and angel scout for Sequoia Capital), and other private investors. UltiHash joined a market where data growth is skyrocketing, and the environment is being taxed for the fuel. Digital data generates a lot of carbon emissions. This rising tide of data will lift the boats with the data storage to facilitate high-performance applications like process optimization and product development.

Blackdot: Building An Automatic Tattooing Device And Online Marketplace Company In Over A $3 Billion Market

By Amit Chowdhry ● Jan 2, 2024

Blackdot is a company that uses new technologies to drive a positive path forward for the art, artists, and people for whom the body is a canvas to tell their stories. And by creating the world’s first automatic tattooing device and providing an online tattoo art marketplace, Blackdot offers tattoo seekers unmatched self-expression through its replicable studio-based tattoo platform. Pulse 2.0 interviewed Blackdot founder and CEO Joel Pennington to learn more about the company.

Voyager Therapeutics Signs $1.2 Billion Capsid License Agreement And Strategic Collaboration With Novartis

By Amit Chowdhry ● Jan 2, 2024

Voyager Therapeutics - a biotechnology company dedicated to advancing neurogenetic medicines - today announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG, to advance potential gene therapies for Huntington’s disease (HD) and spinal muscular atrophy (SMA). And Voyager will provide Novartis a target-exclusive license to access Voyager’s TRACER capsids and other intellectual property for the respective diseases. Voyager and Novartis will collaborate to advance a preclinical gene therapy candidate for HD.